Rufinamide Market Set for Remarkable Growth Amid Rising Epilepsy Cases and Therapeutic Advancements
https://dataintelo.com/rep...
The Rufinamide Market is projected to witness steady growth over the coming years, driven by a rising prevalence of epilepsy disorders, increasing awareness of rare seizure conditions, and ongoing advancements in anticonvulsant drug formulations. As a critical treatment option for Lennox-Gastaut Syndrome (LGS), Rufinamide is gaining widespread clinical adoption worldwide.
https://dataintelo.com/rep...
The Rufinamide Market is projected to witness steady growth over the coming years, driven by a rising prevalence of epilepsy disorders, increasing awareness of rare seizure conditions, and ongoing advancements in anticonvulsant drug formulations. As a critical treatment option for Lennox-Gastaut Syndrome (LGS), Rufinamide is gaining widespread clinical adoption worldwide.
Rufinamide Market Report | Global Forecast From 2025 To 2033
The global rufinamide market size was estimated at USD 228 million in 2023, and it is projected to reach USD 375 million by 2032, with a compound annual growth rate (CAGR) of 5.8% during the forecast period.
https://dataintelo.com/report/global-rufinamide-market
02:54 AM - Jun 11, 2025 (UTC)
